NOTE 14 – ACQUISITION OF BIOLUMINA ASSETS (Tables)

9 Months Ended

Jul. 31, 2025

Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]

Schedule of other Income

Schedule of other Income
		Three Months Ended July 31,
		2025				2024
Other income
Gain on write-off of advances payable to former officer		$	-			$	221,000
Commissions on sales of Exotropin products			19,000				-
Other			3,000				3,000
Total		$	22,000			$	224,000


		Nine Months Ended July 31,
		2025				2024
Other income
Gain on write-off of advances payable to former officer		$	-			$	221,000
Resolution and settlement of long outstanding payables			-				154,000
Commissions on sales of Exotropin products			62,000				87,000
Proceeds from insurance claim			-				89,000
Other			16,000				7,000
Total		$	78,000			$	558,000